This plateau represents a new metabolic equilibrium where your body has reset its hunger/fullness set point and adjusted energy expenditure
Ivim Healths GLP-1 ID program takes a different approach than traditional one-size-fits-all weight loss programs
Almandoz JP, Lingvay I, Morales J, Campos C
This review explores the mechanisms, clinical development, and therapeutic potential of these novel agents, excluding already approved drugs like liraglutide, semaglutide, and tirzepatide
J.LopezH
GLP-1 receptor agonist use was associated with a 74% reduction in the odds of alcohol use disorder, a 69% reduction in the odds of opioid use disorder, a 68% reduction in the odds of nicotine use disorder, and a 75% reduction in the odds of cocaine use disorder